Prosight-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ARGX",
  "ACHC",
  "ABCL",
  "FOLD",
  "GLPG",
  "LIVN",
  "RCKT",
  "MIRM",
  "TECX",
  "ADCT",
  "SNDX",
  "PRTA",
  "JANX",
  "SYRE",
  "ISRG",
  "OKUR",
  "RNTX",
  "SGHT",
  "STTK",
  "ICLR",
  "ZYME",
  "ADUS",
  "SDGR",
  "PLRX",
  "HAE",
  "ROIV",
  "ERAS",
  "IMNM",
  "KURA",
  "BHVN",
  "MURA",
  "IMVT",
  "BPMC",
  "BBIO",
  "CDNA",
  "CRBP",
  "CTMX",
  "MGTX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 38
Total Value: 304343468
Accession Number: 0001420506-25-001167
Form Type: 13F-HR
CIK: prosight-management-lp
Manager Name: Prosight-Management-Lp

Data Enrichment

100% identified

38 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

38 positions • $304.3M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

Immunovant, Inc.

IMVT|45258J102

Shares:360.0K

Value:$6.2M

% of Portfolio:2.0% ($6.2M/$304.3M)

PROTHENA CORP PUBLIC LTD CO

PRTA|G72800108

Shares:408.1K

Value:$5.1M

% of Portfolio:1.7% ($5.1M/$304.3M)

LivaNova PLC

LIVN|G5509L101

Shares:127.3K

Value:$5.0M

% of Portfolio:1.6% ($5.0M/$304.3M)

HAEMONETICS CORP

HAE|405024100

Shares:65.4K

Value:$4.2M

% of Portfolio:1.4% ($4.2M/$304.3M)

Blueprint Medicines Corp

BPMC|09627Y109

Shares:36.5K

Value:$3.2M

% of Portfolio:1.1% ($3.2M/$304.3M)

Corbus Pharmaceuticals Holdings, Inc.

CRBP|21833P301

Shares:575.1K

Value:$3.1M

% of Portfolio:1.0% ($3.1M/$304.3M)

CytomX Therapeutics, Inc.

CTMX|23284F105

Shares:3.9M

Value:$2.5M

% of Portfolio:0.8% ($2.5M/$304.3M)

CareDx, Inc.

CDNA|14167L103

Shares:136.6K

Value:$2.4M

% of Portfolio:0.8% ($2.4M/$304.3M)

Biohaven Ltd.

BHVN|G1110E107

Shares:100.0K

Value:$2.4M

% of Portfolio:0.8% ($2.4M/$304.3M)

Addus HomeCare Corp

ADUS|006739106

Shares:24.0K

Value:$2.4M

% of Portfolio:0.8% ($2.4M/$304.3M)

Sight Sciences, Inc.

SGHT|82657M105

Shares:969.3K

Value:$2.3M

% of Portfolio:0.8% ($2.3M/$304.3M)

Erasca, Inc.

ERAS|29479A108

Shares:947.1K

Value:$1.3M

% of Portfolio:0.4% ($1.3M/$304.3M)

Spyre Therapeutics, Inc.

SYRE|00773J202

Shares:74.9K

Value:$1.2M

% of Portfolio:0.4% ($1.2M/$304.3M)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:186.6K

Value:$802.3K

% of Portfolio:0.3% ($802.3K/$304.3M)

Rein Therapeutics, Inc.

RNTX|00887A204

Shares:430.0K

Value:$761.1K

% of Portfolio:0.3% ($761.1K/$304.3M)

Mural Oncology plc

MURA|G63365103

Shares:422.7K

Value:$532.7K

% of Portfolio:0.2% ($532.7K/$304.3M)

PLIANT THERAPEUTICS, INC.

PLRX|729139105

Shares:334.3K

Value:$451.3K

% of Portfolio:0.1% ($451.3K/$304.3M)

Immunome Inc.

IMNM|45257U108

Shares:23.6K

Value:$158.9K

% of Portfolio:0.1% ($158.9K/$304.3M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Immunovant, Inc.(IMVTcusip45258J102)	360.0K	QoQ +17.83% (-54.5K) YoY +84.61% (-165.0K)	All Managers (Combined)	$6.2M	2.0% ($6.2M/$304.3M)	QoQ -18.70% (-$1.4M) YoY -2.34% (-$148.1K)
PROTHENA CORP PUBLIC LTD CO(PRTAcusipG72800108)	408.1K	QoQ -2.39% (-10.0K) YoY +139.41% (+237.7K)	All Managers (Combined)	$5.1M	1.7% ($5.1M/$304.3M)	QoQ -12.78% (-$740.5K) YoY +19.60% (+$828.0K)
LivaNova PLC(LIVNcusipG5509L101)	127.3K	QoQ +81.85% (+57.3K) YoY NEW(+127.3K)	All Managers (Combined)	$5.0M	1.6% ($5.0M/$304.3M)	QoQ +54.25% (+$1.8M) YoY NEW(+$5.0M)
HAEMONETICS CORP(HAEcusip405024100)	65.4K	QoQ +40.04% (+18.7K) YoY NEW(+65.4K)	All Managers (Combined)	$4.2M	1.4% ($4.2M/$304.3M)	QoQ +13.98% (+$509.8K) YoY NEW(+$4.2M)
Blueprint Medicines Corp(BPMCcusip09627Y109)	36.5K	QoQ -45.50% (-30.5K) YoY NEW(+36.5K)	All Managers (Combined)	$3.2M	1.1% ($3.2M/$304.3M)	QoQ -44.69% (-$2.6M) YoY NEW(+$3.2M)
Corbus Pharmaceuticals Holdings, Inc.(CRBPcusip21833P301)	575.1K	QoQ +113.01% (-305.1K) YoY +471.60% (-474.5K)	All Managers (Combined)	$3.1M	1.0% ($3.1M/$304.3M)	QoQ -4.14% (-$132.0K) YoY -22.64% (-$894.2K)
CytomX Therapeutics, Inc.(CTMXcusip23284F105)	3.9M	QoQ +0.64% (-25.0K) YoY NEW(+3.9M)	All Managers (Combined)	$2.5M	0.8% ($2.5M/$304.3M)	QoQ -37.87% (-$1.5M) YoY NEW(+$2.5M)
CareDx, Inc.(CDNAcusip14167L103)	136.6K	QoQ +70.74% (+56.6K) YoY NEW(+136.6K)	All Managers (Combined)	$2.4M	0.8% ($2.4M/$304.3M)	QoQ +41.55% (+$711.7K) YoY NEW(+$2.4M)
Biohaven Ltd.(BHVNcusipG1110E107)	100.0K	QoQ NEW(+100.0K) YoY NEW(+100.0K)	All Managers (Combined)	$2.4M	0.8% ($2.4M/$304.3M)	QoQ NEW(+$2.4M) YoY NEW(+$2.4M)
Addus HomeCare Corp(ADUScusip006739106)	24.0K	QoQ NEW(+24.0K) YoY NEW(+24.0K)	All Managers (Combined)	$2.4M	0.8% ($2.4M/$304.3M)	QoQ NEW(+$2.4M) YoY NEW(+$2.4M)
Sight Sciences, Inc.(SGHTcusip82657M105)	969.3K	QoQ +6.65% (-60.4K) YoY NEW(+969.3K)	All Managers (Combined)	$2.3M	0.8% ($2.3M/$304.3M)	QoQ -29.68% (-$981.9K) YoY NEW(+$2.3M)
Erasca, Inc.(ERAScusip29479A108)	947.1K	QoQ 0.00% (-0) YoY -74.12% (-2.7M)	All Managers (Combined)	$1.3M	0.4% ($1.3M/$304.3M)	QoQ -45.41% (-$1.1M) YoY -82.78% (-$6.2M)
Spyre Therapeutics, Inc.(SYREcusip00773J202)	74.9K	QoQ -6.34% (-5.1K) YoY NEW(+74.9K)	All Managers (Combined)	$1.2M	0.4% ($1.2M/$304.3M)	QoQ -35.09% (-$653.5K) YoY NEW(+$1.2M)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	186.6K	QoQ +192.64% (+122.8K) YoY NEW(+186.6K)	All Managers (Combined)	$802.3K	0.3% ($802.3K/$304.3M)	QoQ +46.32% (+$254.0K) YoY NEW(+$802.3K)
Rein Therapeutics, Inc.(RNTXcusip00887A204)	430.0K	QoQ +6.17% (-25.0K) YoY NEW(+430.0K)	All Managers (Combined)	$761.1K	0.3% ($761.1K/$304.3M)	QoQ -18.28% (-$170.4K) YoY NEW(+$761.1K)
Mural Oncology plc(MURAcusipG63365103)	422.7K	QoQ -9.44% (-44.1K) YoY +5.68% (-22.7K)	All Managers (Combined)	$532.7K	0.2% ($532.7K/$304.3M)	QoQ -64.56% (-$970.5K) YoY -72.76% (-$1.4M)
PLIANT THERAPEUTICS, INC.(PLRXcusip729139105)	334.3K	QoQ NEW(+334.3K) YoY NEW(+334.3K)	All Managers (Combined)	$451.3K	0.1% ($451.3K/$304.3M)	QoQ NEW(+$451.3K) YoY NEW(+$451.3K)
Immunome Inc.(IMNMcusip45257U108)	23.6K	QoQ -56.53% (-30.7K) YoY NEW(+23.6K)	All Managers (Combined)	$158.9K	0.1% ($158.9K/$304.3M)	QoQ -72.45% (-$418.2K) YoY NEW(+$158.9K)